Annual CFF
$3.99 M
+$4.02 M+14888.89%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual cash flow from financing activities is $3.99 million, with the most recent change of +$4.02 million (+14888.89%) on December 31, 2023.
- During the last 3 years, COCP annual CFF has fallen by -$31.67 million (-88.80%).
- COCP annual CFF is now -89.62% below its all-time high of $38.47 million, reached on December 31, 2021.
Performance
COCP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly cash flow from financing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, COCP quarterly CFF has stayed the same.
- COCP quarterly CFF is now -100.00% below its all-time high of $36.42 million, reached on June 30, 2021.
Performance
COCP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, COCP TTM cash flow from financing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, COCP TTM CFF has dropped by -$3.99 million (-100.00%).
- COCP TTM CFF is now -100.00% below its all-time high of $57.64 million, reached on June 30, 2021.
Performance
COCP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
COCP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | 0.0% | -100.0% |
| 3 y3 years | -88.8% | +100.0% | +100.0% |
| 5 y5 years | -55.1% | +100.0% | +100.0% |
COCP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.6% | >+9999.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| 5 y | 5-year | -89.6% | >+9999.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -89.6% | >+9999.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Cocrystal Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | $4.00 M(+0.2%) |
| Dec 2023 | $3.99 M(<-9900.0%) | $0.00(0.0%) | $3.99 M(+0.2%) |
| Sep 2023 | - | $0.00(-100.0%) | $3.99 M(+0.2%) |
| Jun 2023 | - | $4.00 M(<-9900.0%) | $3.98 M(<-9900.0%) |
| Mar 2023 | - | -$7000.00(0.0%) | -$28.00 K(+3.7%) |
| Dec 2022 | -$27.00 K(-100.1%) | -$7000.00(0.0%) | -$27.00 K(-6.9%) |
| Sep 2022 | - | -$7000.00(0.0%) | -$29.00 K(-12.1%) |
| Jun 2022 | - | -$7000.00(+16.7%) | -$33.00 K(-100.1%) |
| Mar 2022 | - | -$6000.00(-33.3%) | $36.40 M(-5.4%) |
| Dec 2021 | $38.47 M(+7.9%) | -$9000.00(-18.2%) | $38.47 M(-8.6%) |
| Sep 2021 | - | -$11.00 K(-100.0%) | $42.09 M(-27.0%) |
| Jun 2021 | - | $36.42 M(+1665.5%) | $57.64 M(+172.2%) |
| Mar 2021 | - | $2.06 M(-42.9%) | $21.18 M(-40.6%) |
| Dec 2020 | $35.66 M(+455.1%) | $3.61 M(-76.8%) | $35.66 M(+2.8%) |
| Sep 2020 | - | $15.55 M(<-9900.0%) | $34.71 M(+81.5%) |
| Jun 2020 | - | -$44.00 K(-100.3%) | $19.12 M(+0.1%) |
| Mar 2020 | - | $16.55 M(+523.3%) | $19.10 M(+197.3%) |
| Dec 2019 | $6.42 M(-27.8%) | $2.65 M(-6421.4%) | $6.42 M(+69.4%) |
| Sep 2019 | - | -$42.00 K(-35.4%) | $3.79 M(-1.1%) |
| Jun 2019 | - | -$65.00 K(-101.7%) | $3.83 M(-66.9%) |
| Mar 2019 | - | $3.88 M(>+9900.0%) | $11.59 M(+30.3%) |
| Dec 2018 | $8.89 M(+118.0%) | $24.00 K(>+9900.0%) | $8.89 M(-9.9%) |
| Sep 2018 | - | $0.00(-100.0%) | $9.87 M(-0.8%) |
| Jun 2018 | - | $7.68 M(+549.1%) | $9.95 M(+89.0%) |
| Mar 2018 | - | $1.18 M(+18.4%) | $5.26 M(+29.0%) |
| Dec 2017 | $4.08 M(-54.7%) | $1.00 M(+1150.0%) | $4.08 M(+32.5%) |
| Sep 2017 | - | $80.00 K(-97.3%) | $3.08 M(-56.1%) |
| Jun 2017 | - | $3.00 M(>+9900.0%) | $7.01 M(+74.8%) |
| Mar 2017 | - | $0.00(0.0%) | $4.01 M(-55.5%) |
| Dec 2016 | $9.02 M | $0.00(-100.0%) | $9.02 M(-0.0%) |
| Sep 2016 | - | $4.01 M(>+9900.0%) | $9.02 M(+80.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $0.00(-100.0%) | $5.01 M(-44.7%) |
| Mar 2016 | - | $5.01 M(>+9900.0%) | $9.06 M(-43.0%) |
| Dec 2015 | $15.88 M(+454.3%) | $3000.00(>+9900.0%) | $15.88 M(+0.0%) |
| Sep 2015 | - | $0.00(-100.0%) | $15.88 M(-0.4%) |
| Jun 2015 | - | $4.05 M(-65.8%) | $15.94 M(+33.6%) |
| Mar 2015 | - | $11.83 M(>+9900.0%) | $11.93 M(+316.2%) |
| Dec 2014 | $2.87 M(>+9900.0%) | $1000.00(-98.3%) | $2.87 M(-0.0%) |
| Sep 2014 | - | $58.00 K(+52.6%) | $2.87 M(+2.1%) |
| Jun 2014 | - | $38.00 K(-98.6%) | $2.81 M(+1.3%) |
| Mar 2014 | - | $2.77 M(>+9900.0%) | $2.77 M(>+9900.0%) |
| Dec 2013 | $7000.00(-99.6%) | $2000.00(>+9900.0%) | $7000.00(-92.7%) |
| Sep 2013 | - | $0.00(-100.0%) | $95.60 K(-127.0%) |
| Jun 2013 | - | $1000.00(-75.0%) | -$354.70 K(+193.6%) |
| Mar 2013 | - | $4000.00(-95.6%) | -$120.80 K(-107.0%) |
| Dec 2012 | $1.71 M(+197.8%) | $90.60 K(-120.1%) | $1.71 M(-16.6%) |
| Sep 2012 | - | -$450.30 K(-291.7%) | $2.06 M(+161.3%) |
| Jun 2012 | - | $234.90 K(-87.2%) | $786.80 K(-1383.5%) |
| Mar 2012 | - | $1.84 M(+325.2%) | -$61.30 K(-110.7%) |
| Dec 2011 | $575.50 K(+103.3%) | $432.40 K(-125.2%) | $575.40 K(+300.7%) |
| Sep 2011 | - | -$1.72 M(+180.3%) | $143.60 K(-92.8%) |
| Jun 2011 | - | -$613.20 K(-124.8%) | $2.00 M(-27.6%) |
| Mar 2011 | - | $2.48 M(>+9900.0%) | $2.76 M(+874.4%) |
| Dec 2010 | $283.10 K(>+9900.0%) | $600.00(-99.6%) | $283.10 K(+0.2%) |
| Sep 2010 | - | $133.90 K(-9.9%) | $282.50 K(+90.1%) |
| Jun 2010 | - | $148.60 K(>+9900.0%) | $148.60 K(>+9900.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | - | $0.00 | $0.00 |
| Dec 2007 | $102.40 K | - | - |
FAQ
- What is Cocrystal Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Cocrystal Pharma?
- What is Cocrystal Pharma annual CFF year-on-year change?
- What is Cocrystal Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly CFF year-on-year change?
- What is Cocrystal Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cocrystal Pharma?
- What is Cocrystal Pharma TTM CFF year-on-year change?
What is Cocrystal Pharma annual cash flow from financing activities?
The current annual CFF of COCP is $3.99 M
What is the all time high annual CFF for Cocrystal Pharma?
Cocrystal Pharma all-time high annual cash flow from financing activities is $38.47 M
What is Cocrystal Pharma annual CFF year-on-year change?
Over the past year, COCP annual cash flow from financing activities has changed by +$4.02 M (+14888.89%)
What is Cocrystal Pharma quarterly cash flow from financing activities?
The current quarterly CFF of COCP is $0.00
What is the all time high quarterly CFF for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly cash flow from financing activities is $36.42 M
What is Cocrystal Pharma quarterly CFF year-on-year change?
Over the past year, COCP quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Cocrystal Pharma TTM cash flow from financing activities?
The current TTM CFF of COCP is $0.00
What is the all time high TTM CFF for Cocrystal Pharma?
Cocrystal Pharma all-time high TTM cash flow from financing activities is $57.64 M
What is Cocrystal Pharma TTM CFF year-on-year change?
Over the past year, COCP TTM cash flow from financing activities has changed by -$3.99 M (-100.00%)